Latest Financial Health News

West African Resources Limited reported a robust cash flow for the December 2025 quarter, ending with a strong cash position of A$584.1 million. The company’s operating activities generated significant cash inflows, offsetting substantial investing and financing outflows.

3D Energi Limited has voluntarily suspended trading of its shares on the ASX as it navigates funding challenges and the future of its VIC/P79 exploration permit. The suspension will last until early February or until further updates are provided.

Multistack International Limited has announced plans to discontinue its current business operations and is working towards disposing of its Australian subsidiary after continued losses and cash burn.

Supply Network Limited has forecast a solid half-year profit of $22.9 million alongside a fully franked interim dividend of 36 cents per share, signalling steady performance in its supply chain operations.

Nyrada Inc. has secured ethics approval to launch a Phase IIa clinical trial for its heart attack drug Xolatryp®, with patient recruitment set for March 2026. The company maintains a solid cash position of AU$7.12 million as it expands its research into oncology.

InVert Graphite has completed its maiden drilling program at the Kumba deposit in Tanzania, revealing wide zones of high-grade graphite near surface and positioning the Morogoro Project for further advancement.

Pantoro Gold delivered a solid December quarter with strong gold production, robust EBITDA, and promising exploration results at its Norseman Gold Project.

Spheria Emerging Companies Limited announces a fully franked 3.8 cents per share quarterly dividend for December 2025 and initiates monthly dividends of 1.3 cents for February and March 2026 as it transitions dividend payments from quarterly to monthly.

Audeara Ltd reported a strong Q2 FY26 with revenues up 274% year-on-year, securing key regulatory approval in China and expanding its global licensing footprint.

Qoria Limited has reported a record-breaking quarter with annual recurring revenue exceeding US$100 million and a 42% increase in net ARR for Q2 FY2026, reaffirming its strong growth trajectory and FY26 guidance.

Genetic Signatures reported a $3.3 million quarterly revenue with growing international sales and a robust cash position, while preparing for a leadership change.

Rent.com.au has achieved a record quarterly revenue exceeding $1 million, driven by strong recurring income from its RentBond® and RentPay products. This milestone underscores the company’s evolving business model and solid financial footing.